NCT01526369 2025-05-09
TH V THL
Cancer Trials Ireland
Phase 3 Completed
Clinical Trials
5 trialsNCT00004067 2021-04-29
Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
NSABP Foundation Inc
Phase 3 Completed
NCT00625898 2020-09-10
BETH
NSABP Foundation Inc
Phase 3 Terminated
NCT00486668 2016-06-06
A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
NSABP Foundation Inc
Phase 3 Unknown
NCT00309556 2011-12-30
Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer
Austrian Breast & Colorectal Cancer Study Group
Phase 3 Completed